The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

Share Price Information for Atlantic Lithium (ALL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 25.00
Bid: 24.80
Ask: 25.00
Change: 0.00 (0.00%)
Spread: 0.20 (0.806%)
Open: 24.50
High: 25.00
Low: 24.20
Prev. Close: 25.00
ALL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Full Year Trading Update

26 Jun 2012 07:00

RNS Number : 1056G
Allocate Software PLC
26 June 2012
 



ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

 

Full Year Trading Update

 

Allocate Software (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, announces an update on trading for its financial year ended 31 May 2012. The Company's final results will be announced in the week commencing 30 July 2012.

 

Highlights

 

§ Strong financial performance in the year with results expected to be in line with market expectations.

 

§ Healthcare had another successful year securing new customers across the NHS, in the UK private healthcare sector and overseas.

 

§ Completed two acquisitions in the financial year: Zircadian in the UK and RosterOn in Australia. Both performed in line with expectations and the cross-sell of different products into the customer base is beginning to yield encouraging results.

 

§ Defence had a record year, with major contract wins worldwide including the multi million pound agreement with the Australian Defence Forces.

 

Healthcare

 

Because of the drive in the NHS for efficiency and cost savings, market appetite for the Allocate application suite with its proven ROI remained strong, with new customers, new products, licence renewals and extensions. HealthRoster, our e-rostering product, retained its strong competitive position and was selected in the majority of all competitive tenders in the UK during the fiscal year.

 

The release of v10, the fully web-based version of HealthRoster with multi-language capability, positions this product well for further internationalisation. Our Swedish business, Time Care, has again performed well and met expectations as it has now done every year since acquisition. HealthRoster will be available in Swedish as the first internationalisation of HealthRoster in the coming months.

 

Leveraging acquisitions - the integration of HealthRoster and the Zircadian products with the rest of the Allocate suite of products provides customers with an end to end solution from planning to scheduling of the medical workforce. In addition, the integration of HealthRoster and the RosterOn product has created a bespoke leading employment awards interpretation engine for the Australian market. The broadening of our product range is creating significant cross-sell opportunities, in line with our strategy.

 

Defence

 

The Defence business achieved substantial growth and continued diversifying into other geographic regions, generating significant business from overseas. Highlights include:

 

§ Securing a multi-million pound licence contract with the Australian Defence Department extending the use of Defence Suite across the Army, Navy and civilians under military control.

§ Substantial additional Consultancy Services contract extension wins with the Royal Australian Navy, as part of their New Generation Navy programme.

§ Two new Consultancy Services contract wins in NATO within their Force Operations Group, and Special Forces HQ.

§ Extension of the UK Army Support contract to 2014

 

Maritime

 

§ Secured a new licence agreement with McDermott Inc, a major US offshore engineering company, the third in this sector

§ Completed a major Maritime Suite implementation to support SubSea7's global Offshore Oil Services operations

 

 

Ian Bowles, Chief Executive Officer of Allocate commented: "Despite the global economic environment and the macro economics of UK government spending we have executed well in our industry sectors and I am delighted with the performance of Allocate this year, particularly in the second half.

 

"2012 was our sixth consecutive year of record revenue. This consistency of execution, I believe, demonstrates a balance across our business, both in terms of vertical markets and geographical focus, which speaks well to our plans for significant growth over the next three to five years. I am very pleased with this year's performance and look forward to Allocate's continued success in the next financial year".

 

 

Enquiries:

Allocate Software plc

Ian Bowles - Chief Executive Officer

Chris Gale - Chief Financial Officer

Martin Jeffries - Marketing Director

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Michael Meade / Simon Willis/ Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James / John Bick

 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include: Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRNRUOANUAR
Date   Source Headline
7th Oct 20137:11 amRNSNotification of Major Interest in Shares
7th Oct 20137:00 amRNSBlocklisting Application
2nd Oct 201312:55 pmRNSExercise of Share Options
1st Oct 20133:29 pmRNSNotification of Major Interest in Shares
30th Sep 20135:17 pmRNSNotification of Major Interest in Shares
30th Sep 20139:46 amRNSNotification of Major Interest in Shares
30th Sep 20137:00 amRNSNotification of Major Interest in Shares
23rd Sep 20131:28 pmRNSNotification of Major Interest in Shares
23rd Sep 20137:09 amRNSRetirement of Director & Director Shareholding
23rd Sep 20137:05 amRNSExercise of Options & Director/PDMR Shareholding
20th Sep 20137:00 amRNSExercise of Share Options
18th Sep 20132:53 pmRNSDirector Shareholding
28th Aug 20137:00 amRNSExercise of Share Options
9th Aug 20139:01 amRNSExercise of Share Options
2nd Aug 20133:18 pmRNSExercise of Share Options
31st Jul 20131:30 pmRNSDividend Payment Date
23rd Jul 20137:00 amRNSFinal Results
24th Jun 20137:00 amRNSTrading Update
20th May 201310:19 amRNSExercise of Options
15th May 20131:08 pmRNSNotification of Major Interest in Shares
7th May 201310:25 amRNSExercise of Options
2nd May 20139:26 amRNSExercise of Options
29th Apr 20138:31 amRNSExercise of Options
26th Apr 20139:49 amRNSExercise of Options
27th Mar 20135:06 pmRNSExercise of Options
25th Mar 20133:30 pmRNSNotification of Major Interest in Shares
25th Mar 20137:05 amRNSNotification of Major Interest In Shares
22nd Mar 20132:16 pmRNSExercise of Options
6th Mar 20134:30 pmRNSHolding(s) in Company
6th Mar 20132:08 pmRNSHolding(s) in Company
26th Feb 20131:12 pmRNSExercise of Options
11th Feb 201310:59 amRNSHolding(s) in Company
11th Feb 201310:53 amRNSHolding(s) in Company
11th Feb 201310:51 amRNSHolding(s) in Company
5th Feb 20137:00 amRNSHalf Yearly Report
16th Jan 20137:00 amRNSNotice of Results
8th Jan 20137:00 amRNSFirst Half Trading Update
23rd Nov 20123:18 pmRNSResult of AGM
31st Oct 20127:00 amRNSBoard Appointment
29th Oct 20127:00 amRNSNotice of AGM
18th Oct 20127:00 amRNSDirector/PDMR Shareholding
3rd Oct 20129:56 amRNSNotification of Major Interest in Shares
1st Oct 20121:14 pmRNSTrading Update
19th Sep 20124:01 pmRNSExercise of Options
15th Aug 20124:35 pmRNSGrant of Share Options to Directors
15th Aug 20127:05 amRNSAnnual Accounts 2012
13th Aug 20123:27 pmRNSNotification of Major Interest in Shares
13th Aug 201210:15 amRNSNotification of Major Interest in Shares
31st Jul 20127:05 amRNSRecord Final Results FYE 31 May 2012
31st Jul 20127:00 amRNSAcquisition of RealTime Health

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.